Satellos Bioscience, Inc. (MSLE)
6.86
+0.51
(+8.03%)
USD |
NASDAQ |
Nov 06, 10:16
Satellos Bioscience Total Liabilities (Quarterly) : 5.861M for June 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 5.861M |
| March 31, 2026 | 4.563M |
| December 31, 2025 | 4.105M |
| September 30, 2025 | 3.503M |
| June 30, 2025 | 2.77M |
| March 31, 2025 | 2.699M |
| December 31, 2024 | 3.584M |
| September 30, 2024 | 2.681M |
| June 30, 2024 | 2.943M |
| March 31, 2024 | 2.774M |
| December 31, 2023 | 2.748M |
| September 30, 2023 | 1.714M |
| June 30, 2023 | 2.933M |
| March 31, 2023 | 3.635M |
| December 31, 2022 | 2.089M |
| September 30, 2022 | 1.469M |
| June 30, 2022 | 1.615M |
| March 31, 2022 | 1.256M |
| December 31, 2021 | 1.666M |
| September 30, 2021 | 1.712M |
| June 30, 2021 | 7.563M |
| March 31, 2021 | 1.528M |
| December 31, 2020 | 1.031M |
| September 30, 2020 | 0.8197M |
| June 30, 2020 | 0.8212M |
| Date | Value |
|---|---|
| March 31, 2020 | 0.8038M |
| December 31, 2019 | 0.6228M |
| September 30, 2019 | 0.3044M |
| June 30, 2019 | 0.4616M |
| March 31, 2019 | 0.647M |
| December 31, 2018 | 0.5877M |
| September 30, 2018 | 0.4686M |
| June 30, 2018 | 0.6972M |
| March 31, 2018 | 0.1623M |
| December 31, 2017 | 0.2301M |
| September 30, 2017 | 0.1414M |
| June 30, 2017 | 0.0833M |
| March 31, 2017 | 0.1979M |
| December 31, 2016 | 0.1031M |
| September 30, 2016 | 0.1096M |
| June 30, 2016 | 0.0805M |
| March 31, 2016 | 0.0543M |
| December 31, 2015 | 0.0829M |
| September 30, 2015 | 0.0586M |
| June 30, 2015 | 0.0785M |
| March 31, 2015 | 0.7615M |
| December 31, 2014 | 1.361M |
| September 30, 2014 | 2.027M |
| June 30, 2014 | 2.511M |
| March 31, 2014 | 2.376M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Xenon Pharmaceuticals, Inc. | 53.38M |
| Psyence Biomedical Ltd. | 0.9431M |
| Aurinia Pharmaceuticals, Inc. | 168.18M |
| enGene Therapeutics, Inc. | 58.03M |
| Medicus Pharma Ltd. | 20.33M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 65.77M |
| Shareholders Equity (Quarterly) | 59.91M |
| Current Ratio | 11.22 |